Its announcement comes on the heels of an analogous licensing arrangement made available in February to Adastra Labs, which experienced till now focused on crafting cannabis extracts. The licensing deal will come following a radical coverage change to deal with an opioid overdose disaster which includes killed thousands, by decriminalizing litt